Low-Risk Prostate Cancer: Active Surveillance Use Varies by Region

According to a recent cohort study, the use of active surveillance for low-risk prostate cancer is impacted by geographic location, despite a lack of association with Black race, the area's density of specialty physician's, or socioeconomic factors. "Active surveillance is now recognized as the preferred management option for most low-risk prostate cancers to minimize risks of overtreatment," write the investigators, led by first author Samuel L. Washington III, MD, MAS, an Assistant Professor o...
Continue reading

Liver Cancer: Delayed Diagnosis, Increased Mortality in Rural and Low-Income Households

Patients living in low income or rural communities have less access to care for liver disease, leading to worse outcomes and advanced tumor stage at diagnosis for hepatocellular carcinoma (HCC), according to the results of a retrospective analysis now published in the journal Cancer. The investigators, led by first author Robert Wong, MD, of the Department of Gastroenterology and Hepatology at the Veterans Affairs Palo Alto Healthcare System and the Stanford University School of Medicine in Palo...
Continue reading

Thanks to COVID, New Cancer Diagnoses Fell by Nearly Half

During the COVID-19 pandemic, guidelines from the American Society of Clinical Oncology and other organizations have recommended that cancer screening procedures involving in-person visits, such as mammograms and colonoscopies, be postponed. These delays have contributed to a whopping 46.4% drop in the combined rate of new diagnoses for six cancers. This is the finding of a cross-sectional study, results of which have now been published in a research letter in JAMA Network Open, a...
Continue reading

COVID-19 Risk in Cancer Patients: Melvin LK Chua, MBBS, FRCR, PhD, and Conghua Xie, MD, PhD

Last week, a research team under the direction of Conghua Xie, MD, PhD, and Melvin LK Chua, MBBS, FRCR, PhD, reported in JAMA Oncology that patients with cancer at a hospital in Wuhan, China, experienced an increased risk of COVID-19 infection relative to other members of the community. In this interview with i3 Health, Dr. Chua and Dr. Xie discuss their findings and analyze possible factors contributing to the increased risk of COVID-19 infection in patients with cancer. Can you comment on the ...
Continue reading

Head and Neck Cancer: Reducing In-Hospital Mortality With Eric Adjei Boakye, PhD

​Over 4% of head and neck cancer (HNC) patients who are hospitalized die during their stay in the hospital. How can this number be reduced? In a cross-sectional study recently published in JAMA Otolaryngology—Head and Neck Surgery, a research team led by Eric Adjei Boakye, PhD, found that among a variety of other patient- and hospital-related factors, male sex, weekend admissions, and treatment at nonteaching hospitals are associated with increased in-hospital mortality. In this interview with i...
Continue reading

Copyright © 2021 Oncology Data Advisor. All rights reserved.